מקדם חוב לטווח ארוך להון plustherapeutics.com (PSTV)

The long-term debt-to-equity ratio reflects the liability structure of Plus Therapeutics, Inc. (PSTV), where the value of 0.00 corresponds to the current metric. The business relies on stable demand, which makes it resilient to market crises. The development of radiotherapy for various solid tumors minimizes the risks of test failures. Meanwhile, Plus Therapeutics, Inc. (PSTV) strictly adheres to radiation safety and environmental disposal standards.

This metric calculates the proportion of long-term liabilities relative to equity, determining the company's degree of financial leverage. The value is sensitive to quarterly changes in accounts payable and equity issuances. By analyzing the long-term debt-to-equity ratio on the GURU.Markets platform, an investor assesses the stability of the financing structure. For Plus Therapeutics, Inc. (PSTV), this is critical, as geopolitical fragmentation and logistical barriers in isotope supplies limit operating revenue. Under such conditions, a high debt load significantly increases the risk of default.